Related Experiment Video
Updated: Jun 11, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
TIMI frame count as a predictor of major adverse cardiovascular events during the first month after primary PCI
Kamyar Amin1, Naghmeh Nematpour1, Iraj Jafaripour1
1Department of Cardiology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
Insights
Corrected Thrombolysis in Myocardial Infarction (TIMI) frame count (CTFC) did not predict major adverse cardiovascular events (MACE) within one month after primary percutaneous coronary intervention (PPCI). However, good ST segment resolution was linked to fewer events.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Research
Background:
- Assessing predictors of adverse cardiovascular events after primary percutaneous coronary intervention (PPCI) is crucial.
- Corrected Thrombolysis in Myocardial Infarction (TIMI) frame count (CTFC) measures coronary blood flow.
- Major adverse cardiovascular events (MACE) include cardiac death, revascularization, and myocardial infarction.
Purpose of the Study:
- To evaluate the correlation between CTFC and MACE in the first month post-PPCI.
- To determine if CTFC can predict short-term adverse outcomes after PPCI.
- To explore the relationship between ST segment resolution and MACE.
Main Methods:
- Eighty patients undergoing PPCI were analyzed.
- CTFC and ST segment resolution were assessed.
- Demographic, clinical data, and MACE were recorded and statistically analyzed.
Main Results:
- No significant association was found between CTFC and MACE (P=0.30).
- 13.7% of patients experienced MACE, including 7 cardiac deaths.
- ST segment resolution >50% was observed in 51.2% of patients and associated with lower MACE prevalence.
Conclusions:
- CTFC is not a reliable predictor of MACE within one month after PPCI.
- ST segment resolution >50% may indicate a better prognosis and lower risk of cardiovascular events.
Background:
This study evaluated the correlation between corrected Thrombolysis in Myocardial Infarction (TIMI) frame count (CTFC) and major adverse cardiovascular events (MACE) within the first month following primary percutaneous coronary intervention (PPCI).
Methods:
Eighty patients who underwent PPCI at Ayatollah Rouhani teaching Hospital in Babol Eighty patients who underwent PPCI at Ayatollah Rouhani teaching Hospital in Babol were included. CTFC, a measure of coronary blood flow, was assessed. Demographic and clinical data, were collected. ST segment resolution, a criterion for successful PPCI, was evaluated. MACE, including cardiac deaths, need for repeat revascularization of culprit vessels, and recurrent non-fatal myocardial infarction, and CVA (cerebrovascular accident) were recorded. Statistical analyses were performed to assess the association between CTFC and demographic/clinical variables, as well as ST resolution and MACE.
Results:
The majority of patients were (78.8%) men and (81.2%) nonsmokers. No significant association was found between CTFC and demographic/clinical variables. The left anterior descending (LAD) artery was the most commonly involved vessel (48.8%). ST segment resolution of more than 50% was observed in 51.2% of patients. During the one-month follow-up, 13.7% of patients experienced MACE, including 7 cardiac deaths. However, there was no significant association between CTFC and MACE. (P=0.30).
Conclusion:
This study concludes that CTFC is not a reliable predictor of MACE within the first month after PPCI. Furthermore, ST segment resolution of more than 50% was associated with a lower prevalence of cardiovascular events.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
14:19Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
Published on: October 14, 2016
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
Acute Coronary SyndromeI: Introduction
Acute Coronary Syndrome III: Diagnostic studies
Imaging Studies for Cardiovascular System V: CT